Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We began analyzing https://www.nature.com/articles/415530a, but it redirected us to https://www.nature.com/articles/415530a. The analysis below is for the second page.

Title[redir]:
Gene expression profiling predicts clinical outcome of breast cancer | Nature
Description:
Breast cancer patients with the same stage of disease can have markedly different treatment responses and overall outcome. The strongest predictors for metastases (for example, lymph node status and histological grade) fail to classify accurately breast tumours according to their clinical behaviour1,2,3. Chemotherapy or hormonal therapy reduces the risk of distant metastases by approximately one-third; however, 70–80% of patients receiving this treatment would have survived without it4,5. None of the signatures of breast cancer gene expression reported to date6,7,8,9,10,11,12 allow for patient-tailored therapy strategies. Here we used DNA microarray analysis on primary breast tumours of 117 young patients, and applied supervised classification to identify a gene expression signature strongly predictive of a short interval to distant metastases (‘poor prognosis’ signature) in patients without tumour cells in local lymph nodes at diagnosis (lymph node negative). In addition, we established a signature that identifies tumours of BRCA1 carriers. The poor prognosis signature consists of genes regulating cell cycle, invasion, metastasis and angiogenesis. This gene expression profile will outperform all currently used clinical parameters in predicting disease outcome. Our findings provide a strategy to select patients who would benefit from adjuvant therapy.

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 96,105,781 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure how the site profits.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Doi.org could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

cancer, breast, article, google, scholar, cas, nature, gene, expression, van, supplementary, access, natl, content, profiling, patients, pdf, ads, cookies, clinical, mao, brca, inst, figure, privacy, data, information, friend, therapy, usa, molecular, res, pubmed, profiles, research, journal, outcome, veer, dai, vijver, roberts, stephen, lymph, tumours, signature, open, prognostic, early, patterns, cancers,

Topics {✒️}

nature portfolio permissions reprints privacy policy advertising social media nature biotechnol nature med nature 406 nature 382 nature 415 nature patient-tailored therapy strategies ink-jet oligonucleotide synthesizer urokinase-type plasminogen activator early breast cancer author correspondence chromatin accessibility profiling lymph node negative development gene expression profiling gene expression patterns permissions gene expression profiles gene-expression profiles personal data springerlink instant access journals search log gene expression profile invasive breast cancer data protection breast cancer laura human breast cancer primary breast cancer breast cancer cells hereditary breast cancer lymph node status optimizing gene selection breast cancer res privacy hormonal therapy reduces human breast tumours cyclin d1 expression primary breast tumours international consensus panel �poor prognosis’ signature natl cancer inst local lymph nodes netherlands cancer institute van der velde pivotal genes shared

Questions {❓}

  • Microarrays—the 21st century divining rod?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Gene expression profiling predicts clinical outcome of breast cancer
         description:Breast cancer patients with the same stage of disease can have markedly different treatment responses and overall outcome. The strongest predictors for metastases (for example, lymph node status and histological grade) fail to classify accurately breast tumours according to their clinical behaviour1,2,3. Chemotherapy or hormonal therapy reduces the risk of distant metastases by approximately one-third; however, 70–80% of patients receiving this treatment would have survived without it4,5. None of the signatures of breast cancer gene expression reported to date6,7,8,9,10,11,12 allow for patient-tailored therapy strategies. Here we used DNA microarray analysis on primary breast tumours of 117 young patients, and applied supervised classification to identify a gene expression signature strongly predictive of a short interval to distant metastases (‘poor prognosis’ signature) in patients without tumour cells in local lymph nodes at diagnosis (lymph node negative). In addition, we established a signature that identifies tumours of BRCA1 carriers. The poor prognosis signature consists of genes regulating cell cycle, invasion, metastasis and angiogenesis. This gene expression profile will outperform all currently used clinical parameters in predicting disease outcome. Our findings provide a strategy to select patients who would benefit from adjuvant therapy.
         datePublished:
         dateModified:
         pageStart:530
         pageEnd:536
         sameAs:https://doi.org/10.1038/415530a
         keywords:
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2F415530a/MediaObjects/41586_2002_Article_BF415530a_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2F415530a/MediaObjects/41586_2002_Article_BF415530a_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2F415530a/MediaObjects/41586_2002_Article_BF415530a_Fig3_HTML.jpg
         isPartOf:
            name:Nature
            issn:
               1476-4687
               0028-0836
            volumeNumber:415
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Laura J. van 't Veer
               affiliation:
                     name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                     address:
                        name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hongyue Dai
               affiliation:
                     name:Rosetta Inpharmatics
                     address:
                        name:Rosetta Inpharmatics, Kirkland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marc J. van de Vijver
               affiliation:
                     name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                     address:
                        name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yudong D. He
               affiliation:
                     name:Rosetta Inpharmatics
                     address:
                        name:Rosetta Inpharmatics, Kirkland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Augustinus A. M. Hart
               affiliation:
                     name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                     address:
                        name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mao Mao
               affiliation:
                     name:Rosetta Inpharmatics
                     address:
                        name:Rosetta Inpharmatics, Kirkland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hans L. Peterse
               affiliation:
                     name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                     address:
                        name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Karin van der Kooy
               affiliation:
                     name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                     address:
                        name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Matthew J. Marton
               affiliation:
                     name:Rosetta Inpharmatics
                     address:
                        name:Rosetta Inpharmatics, Kirkland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anke T. Witteveen
               affiliation:
                     name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                     address:
                        name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:George J. Schreiber
               affiliation:
                     name:Rosetta Inpharmatics
                     address:
                        name:Rosetta Inpharmatics, Kirkland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ron M. Kerkhoven
               affiliation:
                     name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                     address:
                        name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chris Roberts
               affiliation:
                     name:Rosetta Inpharmatics
                     address:
                        name:Rosetta Inpharmatics, Kirkland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter S. Linsley
               affiliation:
                     name:Rosetta Inpharmatics
                     address:
                        name:Rosetta Inpharmatics, Kirkland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:René Bernards
               affiliation:
                     name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                     address:
                        name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stephen H. Friend
               affiliation:
                     name:Rosetta Inpharmatics
                     address:
                        name:Rosetta Inpharmatics, Kirkland, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Gene expression profiling predicts clinical outcome of breast cancer
      description:Breast cancer patients with the same stage of disease can have markedly different treatment responses and overall outcome. The strongest predictors for metastases (for example, lymph node status and histological grade) fail to classify accurately breast tumours according to their clinical behaviour1,2,3. Chemotherapy or hormonal therapy reduces the risk of distant metastases by approximately one-third; however, 70–80% of patients receiving this treatment would have survived without it4,5. None of the signatures of breast cancer gene expression reported to date6,7,8,9,10,11,12 allow for patient-tailored therapy strategies. Here we used DNA microarray analysis on primary breast tumours of 117 young patients, and applied supervised classification to identify a gene expression signature strongly predictive of a short interval to distant metastases (‘poor prognosis’ signature) in patients without tumour cells in local lymph nodes at diagnosis (lymph node negative). In addition, we established a signature that identifies tumours of BRCA1 carriers. The poor prognosis signature consists of genes regulating cell cycle, invasion, metastasis and angiogenesis. This gene expression profile will outperform all currently used clinical parameters in predicting disease outcome. Our findings provide a strategy to select patients who would benefit from adjuvant therapy.
      datePublished:
      dateModified:
      pageStart:530
      pageEnd:536
      sameAs:https://doi.org/10.1038/415530a
      keywords:
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2F415530a/MediaObjects/41586_2002_Article_BF415530a_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2F415530a/MediaObjects/41586_2002_Article_BF415530a_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2F415530a/MediaObjects/41586_2002_Article_BF415530a_Fig3_HTML.jpg
      isPartOf:
         name:Nature
         issn:
            1476-4687
            0028-0836
         volumeNumber:415
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Laura J. van 't Veer
            affiliation:
                  name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                  address:
                     name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hongyue Dai
            affiliation:
                  name:Rosetta Inpharmatics
                  address:
                     name:Rosetta Inpharmatics, Kirkland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marc J. van de Vijver
            affiliation:
                  name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                  address:
                     name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yudong D. He
            affiliation:
                  name:Rosetta Inpharmatics
                  address:
                     name:Rosetta Inpharmatics, Kirkland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Augustinus A. M. Hart
            affiliation:
                  name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                  address:
                     name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mao Mao
            affiliation:
                  name:Rosetta Inpharmatics
                  address:
                     name:Rosetta Inpharmatics, Kirkland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hans L. Peterse
            affiliation:
                  name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                  address:
                     name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Karin van der Kooy
            affiliation:
                  name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                  address:
                     name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Matthew J. Marton
            affiliation:
                  name:Rosetta Inpharmatics
                  address:
                     name:Rosetta Inpharmatics, Kirkland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anke T. Witteveen
            affiliation:
                  name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                  address:
                     name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:George J. Schreiber
            affiliation:
                  name:Rosetta Inpharmatics
                  address:
                     name:Rosetta Inpharmatics, Kirkland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ron M. Kerkhoven
            affiliation:
                  name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                  address:
                     name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chris Roberts
            affiliation:
                  name:Rosetta Inpharmatics
                  address:
                     name:Rosetta Inpharmatics, Kirkland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter S. Linsley
            affiliation:
                  name:Rosetta Inpharmatics
                  address:
                     name:Rosetta Inpharmatics, Kirkland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:René Bernards
            affiliation:
                  name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
                  address:
                     name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stephen H. Friend
            affiliation:
                  name:Rosetta Inpharmatics
                  address:
                     name:Rosetta Inpharmatics, Kirkland, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature
      issn:
         1476-4687
         0028-0836
      volumeNumber:415
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
      address:
         name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
         type:PostalAddress
      name:Rosetta Inpharmatics
      address:
         name:Rosetta Inpharmatics, Kirkland, USA
         type:PostalAddress
      name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
      address:
         name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
         type:PostalAddress
      name:Rosetta Inpharmatics
      address:
         name:Rosetta Inpharmatics, Kirkland, USA
         type:PostalAddress
      name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
      address:
         name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
         type:PostalAddress
      name:Rosetta Inpharmatics
      address:
         name:Rosetta Inpharmatics, Kirkland, USA
         type:PostalAddress
      name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
      address:
         name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
         type:PostalAddress
      name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
      address:
         name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
         type:PostalAddress
      name:Rosetta Inpharmatics
      address:
         name:Rosetta Inpharmatics, Kirkland, USA
         type:PostalAddress
      name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
      address:
         name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
         type:PostalAddress
      name:Rosetta Inpharmatics
      address:
         name:Rosetta Inpharmatics, Kirkland, USA
         type:PostalAddress
      name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
      address:
         name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
         type:PostalAddress
      name:Rosetta Inpharmatics
      address:
         name:Rosetta Inpharmatics, Kirkland, USA
         type:PostalAddress
      name:Rosetta Inpharmatics
      address:
         name:Rosetta Inpharmatics, Kirkland, USA
         type:PostalAddress
      name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
      address:
         name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
         type:PostalAddress
      name:Rosetta Inpharmatics
      address:
         name:Rosetta Inpharmatics, Kirkland, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Laura J. van 't Veer
      affiliation:
            name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
            address:
               name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Hongyue Dai
      affiliation:
            name:Rosetta Inpharmatics
            address:
               name:Rosetta Inpharmatics, Kirkland, USA
               type:PostalAddress
            type:Organization
      name:Marc J. van de Vijver
      affiliation:
            name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
            address:
               name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Yudong D. He
      affiliation:
            name:Rosetta Inpharmatics
            address:
               name:Rosetta Inpharmatics, Kirkland, USA
               type:PostalAddress
            type:Organization
      name:Augustinus A. M. Hart
      affiliation:
            name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
            address:
               name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Mao Mao
      affiliation:
            name:Rosetta Inpharmatics
            address:
               name:Rosetta Inpharmatics, Kirkland, USA
               type:PostalAddress
            type:Organization
      name:Hans L. Peterse
      affiliation:
            name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
            address:
               name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Karin van der Kooy
      affiliation:
            name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
            address:
               name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Matthew J. Marton
      affiliation:
            name:Rosetta Inpharmatics
            address:
               name:Rosetta Inpharmatics, Kirkland, USA
               type:PostalAddress
            type:Organization
      name:Anke T. Witteveen
      affiliation:
            name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
            address:
               name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:George J. Schreiber
      affiliation:
            name:Rosetta Inpharmatics
            address:
               name:Rosetta Inpharmatics, Kirkland, USA
               type:PostalAddress
            type:Organization
      name:Ron M. Kerkhoven
      affiliation:
            name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
            address:
               name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Chris Roberts
      affiliation:
            name:Rosetta Inpharmatics
            address:
               name:Rosetta Inpharmatics, Kirkland, USA
               type:PostalAddress
            type:Organization
      name:Peter S. Linsley
      affiliation:
            name:Rosetta Inpharmatics
            address:
               name:Rosetta Inpharmatics, Kirkland, USA
               type:PostalAddress
            type:Organization
      name:René Bernards
      affiliation:
            name:Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute
            address:
               name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Stephen H. Friend
      affiliation:
            name:Rosetta Inpharmatics
            address:
               name:Rosetta Inpharmatics, Kirkland, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
      name:Rosetta Inpharmatics, Kirkland, USA
      name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
      name:Rosetta Inpharmatics, Kirkland, USA
      name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
      name:Rosetta Inpharmatics, Kirkland, USA
      name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
      name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
      name:Rosetta Inpharmatics, Kirkland, USA
      name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
      name:Rosetta Inpharmatics, Kirkland, USA
      name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
      name:Rosetta Inpharmatics, Kirkland, USA
      name:Rosetta Inpharmatics, Kirkland, USA
      name:Divisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands
      name:Rosetta Inpharmatics, Kirkland, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(253)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

4.09s.